<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments for Impactiviti blog</title>
	<atom:link href="http://impactiviti.wordpress.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://impactiviti.wordpress.com</link>
	<description>Impact. We Recommend it.</description>
	<lastBuildDate>Sat, 21 Nov 2009 18:39:45 +0000</lastBuildDate>
	<generator>http://wordpress.com/</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>Comment on The Pitfall of Doing Nothing by @StetsonClowes</title>
		<link>http://impactiviti.wordpress.com/2009/11/03/the-pitfall-of-doing-nothing/#comment-34136</link>
		<dc:creator>@StetsonClowes</dc:creator>
		<pubDate>Sat, 21 Nov 2009 18:39:45 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1992#comment-34136</guid>
		<description>Well said.  I&#039;m sharing this with my colleagues--though I am not in pharma, the same issues apply.  I like the twitter headline ROI, return on ignoring...</description>
		<content:encoded><![CDATA[<p>Well said.  I&#8217;m sharing this with my colleagues&#8211;though I am not in pharma, the same issues apply.  I like the twitter headline ROI, return on ignoring&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Google&#8217;s Sidewiki &#8211; Game-changer for Pharma Social Media? by Mihai</title>
		<link>http://impactiviti.wordpress.com/2009/09/29/googles-sidewiki-game-changer-for-pharma-social-media/#comment-34090</link>
		<dc:creator>Mihai</dc:creator>
		<pubDate>Wed, 18 Nov 2009 01:08:53 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1862#comment-34090</guid>
		<description>Not only there is nothing to fear for the big companies, but they have good reasons to be happy about this.

While up to now negative comments accumulate in tons of disparate blogs/forums and PR folks have to police and influence lots of places, the comments will now cluster around the company homepage, which is a location easier to monitor and influence.   

Companies will use this space in the same way they use &quot;flogs&quot; (search for it) or they will hire 3rd parties to trash the competition.
It is not surprising google is pushing this feature as ability to control the messaging in these areas, including ad space, is going to be pretty expensive.

For the user population, there is nothing to be happy about wrt this feature.</description>
		<content:encoded><![CDATA[<p>Not only there is nothing to fear for the big companies, but they have good reasons to be happy about this.</p>
<p>While up to now negative comments accumulate in tons of disparate blogs/forums and PR folks have to police and influence lots of places, the comments will now cluster around the company homepage, which is a location easier to monitor and influence.   </p>
<p>Companies will use this space in the same way they use &#8220;flogs&#8221; (search for it) or they will hire 3rd parties to trash the competition.<br />
It is not surprising google is pushing this feature as ability to control the messaging in these areas, including ad space, is going to be pretty expensive.</p>
<p>For the user population, there is nothing to be happy about wrt this feature.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Those Dreaded Capabilities Presentations! by Should You Ever Bypass an RFP Process?</title>
		<link>http://impactiviti.wordpress.com/2009/10/07/those-dreaded-capabilities-presentations/#comment-34075</link>
		<dc:creator>Should You Ever Bypass an RFP Process?</dc:creator>
		<pubDate>Mon, 16 Nov 2009 19:21:42 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1898#comment-34075</guid>
		<description>[...] Those Dreaded Capabilities Presentations! (impactiviti.wordpress.com) [...]</description>
		<content:encoded><![CDATA[<p>[...] Those Dreaded Capabilities Presentations! (impactiviti.wordpress.com) [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Disease Guilt by Blind Spots and Broken Limbs &#171; Steve&#8217;s Leaves</title>
		<link>http://impactiviti.wordpress.com/2009/10/27/disease-guilt/#comment-34069</link>
		<dc:creator>Blind Spots and Broken Limbs &#171; Steve&#8217;s Leaves</dc:creator>
		<pubDate>Mon, 16 Nov 2009 15:15:10 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1956#comment-34069</guid>
		<description>[...] of childhood abuse. Parents or spouses or children afflicted with persistent medical conditions. Disease guilt. Wayward children. And the multitude of other limp-creating troubles that we don&#8217;t like to [...]</description>
		<content:encoded><![CDATA[<p>[...] of childhood abuse. Parents or spouses or children afflicted with persistent medical conditions. Disease guilt. Wayward children. And the multitude of other limp-creating troubles that we don&#8217;t like to [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on The Pitfall of Doing Nothing by Bill Senger</title>
		<link>http://impactiviti.wordpress.com/2009/11/03/the-pitfall-of-doing-nothing/#comment-33889</link>
		<dc:creator>Bill Senger</dc:creator>
		<pubDate>Fri, 06 Nov 2009 14:05:34 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1992#comment-33889</guid>
		<description>Right on, Steve! Once again you have identified the later-adaptors among the pharmaceutical industry. I personally feel that every pharma industry consumer-support resident chip-head should be able to deliver to online consumers and online presence in DTP communications, which contributes vale-added benefit to the consumer for the product in question. The cost to marketing or project management would be minimal, but the rewards could be enormous.</description>
		<content:encoded><![CDATA[<p>Right on, Steve! Once again you have identified the later-adaptors among the pharmaceutical industry. I personally feel that every pharma industry consumer-support resident chip-head should be able to deliver to online consumers and online presence in DTP communications, which contributes vale-added benefit to the consumer for the product in question. The cost to marketing or project management would be minimal, but the rewards could be enormous.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on The Pitfall of Doing Nothing by Jeremy Meyers</title>
		<link>http://impactiviti.wordpress.com/2009/11/03/the-pitfall-of-doing-nothing/#comment-33819</link>
		<dc:creator>Jeremy Meyers</dc:creator>
		<pubDate>Wed, 04 Nov 2009 15:49:37 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1992#comment-33819</guid>
		<description>Not making a decision is a decision as well.</description>
		<content:encoded><![CDATA[<p>Not making a decision is a decision as well.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on The Pitfall of Doing Nothing by PhilFeed &#8250; Fresh From My Twitter today</title>
		<link>http://impactiviti.wordpress.com/2009/11/03/the-pitfall-of-doing-nothing/#comment-33803</link>
		<dc:creator>PhilFeed &#8250; Fresh From My Twitter today</dc:creator>
		<pubDate>Wed, 04 Nov 2009 00:42:33 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1992#comment-33803</guid>
		<description>[...] RT @swoodruff: The Pitfall of Doing Nothing &#8211; Inaction, Pharma, and Social Media. http://bit.ly/IMvS7 #efp RT @jonmrich: Need help 4 my FDA hearing presentation: Show me examples of worst medical [...]</description>
		<content:encoded><![CDATA[<p>[...] RT @swoodruff: The Pitfall of Doing Nothing &#8211; Inaction, Pharma, and Social Media. <a href="http://bit.ly/IMvS7" rel="nofollow">http://bit.ly/IMvS7</a> #efp RT @jonmrich: Need help 4 my FDA hearing presentation: Show me examples of worst medical [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on The Pitfall of Doing Nothing by Chris P</title>
		<link>http://impactiviti.wordpress.com/2009/11/03/the-pitfall-of-doing-nothing/#comment-33802</link>
		<dc:creator>Chris P</dc:creator>
		<pubDate>Tue, 03 Nov 2009 23:39:19 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1992#comment-33802</guid>
		<description>If you move too fast then marketing will get ahead of legal. When legal reins marketing back in, it may be to the point of stopping the wagon completely.  

A fast follower can learn from the mistakes of others and navigate around the pitfalls and come out ahead.  

Burying your head in the sand like an ostrich is the wrong strategy.  Watch from the sidelines, talk to the players and the coaches, and make sure you have the right equipment on and know the rules before you go out on the field.  Let the other players teach you what icing and offsides are, then when you join the game, you can score without having the play called back.  A career-ending injury or spending part of the game in the penalty box should be left to those with higher tolerance for risk.</description>
		<content:encoded><![CDATA[<p>If you move too fast then marketing will get ahead of legal. When legal reins marketing back in, it may be to the point of stopping the wagon completely.  </p>
<p>A fast follower can learn from the mistakes of others and navigate around the pitfalls and come out ahead.  </p>
<p>Burying your head in the sand like an ostrich is the wrong strategy.  Watch from the sidelines, talk to the players and the coaches, and make sure you have the right equipment on and know the rules before you go out on the field.  Let the other players teach you what icing and offsides are, then when you join the game, you can score without having the play called back.  A career-ending injury or spending part of the game in the penalty box should be left to those with higher tolerance for risk.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on The Pitfall of Doing Nothing by Regulatory Requirements: A Convenient Excuse for Pharma to Avoid Social Media &#124; PRforPharma</title>
		<link>http://impactiviti.wordpress.com/2009/11/03/the-pitfall-of-doing-nothing/#comment-33801</link>
		<dc:creator>Regulatory Requirements: A Convenient Excuse for Pharma to Avoid Social Media &#124; PRforPharma</dc:creator>
		<pubDate>Tue, 03 Nov 2009 23:10:13 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1992#comment-33801</guid>
		<description>[...] the same lines, Sean Woodruff of the Impactiviti Blog wrote a post today on the Pitfalls of Doing Nothing.  His point (overly simplified here but I suggest you pop over and read the post in full) was that [...]</description>
		<content:encoded><![CDATA[<p>[...] the same lines, Sean Woodruff of the Impactiviti Blog wrote a post today on the Pitfalls of Doing Nothing.  His point (overly simplified here but I suggest you pop over and read the post in full) was that [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on I Was There (Digital Pharma 2009) by Shaking Things Up &#171; StickyFigure</title>
		<link>http://impactiviti.wordpress.com/2009/10/22/i-was-there-digital-pharma-2009/#comment-33797</link>
		<dc:creator>Shaking Things Up &#171; StickyFigure</dc:creator>
		<pubDate>Tue, 03 Nov 2009 18:56:50 +0000</pubDate>
		<guid isPermaLink="false">http://impactiviti.wordpress.com/?p=1934#comment-33797</guid>
		<description>[...] that&#8217;s what your audience is doing.  I&#8217;m impatient with a lack of daring. Try newthings. Shake things up. Get some creative thinkers in your advisory board and plan, from 9-12 months out, [...]</description>
		<content:encoded><![CDATA[<p>[...] that&#8217;s what your audience is doing.  I&#8217;m impatient with a lack of daring. Try newthings. Shake things up. Get some creative thinkers in your advisory board and plan, from 9-12 months out, [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
